Published Manuscripts (2010)

Palmer JL, Beaudet A, White J, Plun-Favreau J, Smith-Palmer J. Cost-effectiveness of biphasic insulin aspart versus insulin glargine in patients with type 2 diabetes in China. Advances in Therapy 2010; 27(11): 814-27.

Pollock RF, Valentine WJ, Goodall G, Brändle M. Evaluating the cost-effectiveness of self-monitoring of blood glucose in type 2 diabetes patients on oral anti-diabetic agents: A long-term modelling study in Switzerland. Swiss Medical Weekly 2010; 140: w13103.

Smith-Palmer J, Curtis BH, Boye KS, Goodall G, Pillemer SR. Anti-CD3 monoclonal antibody treatment in newly diagnosed type 1 diabetes patients: a hypothetical modelling analysis. Diabetic Medicine 2010; 27(2): 189-96.

Valentine WJ, Pollock RF, Plun-Favreau J, White J. Systematic review of the cost-effectiveness of biphasic insulin aspart 30 in type 2 diabetes. Current Medical Research and Opinion 2010; 26(6): 1399-412.